Article info

Download PDFPDF
Sequential therapy with ranibizumab and dexamethasone intravitreal implant is better than dexamethasone monotherapy for macular oedema due to retinal vein occlusion

Authors

  1. Correspondence to Dr Ian Y Wong, Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Room 301, Level 3, Block B, Cyberport 4, Pokfulam, Hong Kong; ianyhwong{at}gmail.com
View Full Text

Citation

Iu LP, Zhao P, Yeung IY, et al
Sequential therapy with ranibizumab and dexamethasone intravitreal implant is better than dexamethasone monotherapy for macular oedema due to retinal vein occlusion

Publication history

  • Received June 10, 2014
  • Revised July 12, 2014
  • Accepted July 19, 2014
  • First published August 19, 2014.
Online issue publication 
January 20, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.